Bowleven plc Block Admission Update

RNS Number : 5058Q

Bowleven plc

30 May 2024

 

 

 

 

30 May 2024

 

 

Bowleven plc ('Bowleven')

Block Admission Update

                                                                                        

 

Bowleven plc ("Bowleven" or the "Company") announces, in connection with its block admission originally announced on 8 May 2018, that all share options issued pursuant to its Approved CSOP Scheme and Schedule 4 CSOP Scheme, have now either been exercised or lapsed. As such, the Company's block admission in respect of a residual amount of 659,526 ordinary shares of 0.1 pence each ("Ordinary Shares") will be cancelled, with no further Ordinary Shares having been issued since its block admission return released on 9 May 2024.

 

The Company's issued share capital as at today remains unchanged with a total of 1,897,772,933 Ordinary Shares in issue. The Company holds 11,913,609 Ordinary Shares in treasury.  The total number of voting rights in the Company is therefore 1,885,859,324. This number should be used by shareholders as the denominator for the calculation of notifiable interests in, or changes to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

ENQUIRIES

 

For further information, please contact:

 

Bowleven plc
Eli Chahin, Chief Executive	00 44 20 3327 0150
Camarco (Financial PR)
Owen Roberts	00 44 20 3757 4980
Hugo Liddy
Shore Capital (NOMAD and Broker)
Daniel Bush Rachel Goldstein	00 44 20 7408 4090

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCFLFSFESIIVIS